| Abstrakt: |
Alzheimer Disease, Brain Diseases and Conditions, Central Nervous System Diseases and Conditions, Dementia, Drugs and Therapies, Health and Medicine, Imidazole Therapy, Neurodegenerative Diseases and Conditions, Neuroinflammation, Pharmaceuticals, Risk and Prevention, Tauopathies Keywords for this news article include: Institute of Biomedicine, Pharmaceuticals, Dementia, Tauopathies, Alzheimer Disease, Imidazole Therapy, Neuroinflammation, Drugs and Therapies, Health and Medicine, Risk and Prevention, Brain Diseases and Conditions, Neurodegenerative Diseases and Conditions, Central Nervous System Diseases and Conditions. Keywords: Alzheimer Disease; Brain Diseases and Conditions; Central Nervous System Diseases and Conditions; Dementia; Drugs and Therapies; Health and Medicine; Imidazole Therapy; Neurodegenerative Diseases and Conditions; Neuroinflammation; Pharmaceuticals; Risk and Prevention; Tauopathies EN Alzheimer Disease Brain Diseases and Conditions Central Nervous System Diseases and Conditions Dementia Drugs and Therapies Health and Medicine Imidazole Therapy Neurodegenerative Diseases and Conditions Neuroinflammation Pharmaceuticals Risk and Prevention Tauopathies 741 741 1 10/16/23 20231020 NES 231020 2023 OCT 20 (NewsRx) -- By a News Reporter-Staff News Editor at Drug Week -- Investigators publish new report on Alzheimer disease. [Extracted from the article] |
